相似文献
1
Moving targets: Emerging roles for MMPs in cancer progression and metastasis.
Matrix Biol. 2015 May-Jul;44-46:200-6. doi: 10.1016/j.matbio.2015.01.019. Epub 2015 Jan 31.
2
Matrix metalloproteinases participation in the metastatic process and their diagnostic and therapeutic applications in cancer.
Crit Rev Oncol Hematol. 2019 May;137:57-83. doi: 10.1016/j.critrevonc.2019.02.010. Epub 2019 Mar 3.
3
[The role of matrixmetalloproteinases in the tumor growth and metastasis].
Khirurgiia (Sofiia). 2010(1):44-9.
4
Critical appraisal of the use of matrix metalloproteinase inhibitors in cancer treatment.
Oncogene. 2000 Dec 27;19(56):6642-50. doi: 10.1038/sj.onc.1204097.
5
Matrix metalloproteinases in stem cell regulation and cancer.
Matrix Biol. 2015 May-Jul;44-46:184-90. doi: 10.1016/j.matbio.2015.01.022. Epub 2015 Feb 3.
6
Biological activity and clinical implications of the matrix metalloproteinases.
Anticancer Res. 2008 Mar-Apr;28(2B):1389-97.
7
Matrix metalloproteinase inhibitors and cancer: trials and tribulations.
Science. 2002 Mar 29;295(5564):2387-92. doi: 10.1126/science.1067100.
8
MMP-Responsive 'Smart' Drug Delivery and Tumor Targeting.
Trends Pharmacol Sci. 2018 Aug;39(8):766-781. doi: 10.1016/j.tips.2018.06.003.
9
Seesaw of matrix metalloproteinases (MMPs).
J Cancer Res Ther. 2016 Jan-Mar;12(1):28-35. doi: 10.4103/0973-1482.157337.
10
Selective small-molecule inhibitors as chemical tools to define the roles of matrix metalloproteinases in disease.
Biochim Biophys Acta Mol Cell Res. 2017 Nov;1864(11 Pt A):2001-2014. doi: 10.1016/j.bbamcr.2017.04.011. Epub 2017 Apr 20.
引用本文的文献
1
TUFT1 Modulates Cell Proliferation, Migration, Invasion, Stemness and EGFR Signaling in Cervical Cancer through Interacting with and Targeting ATF1.
Cell Biochem Biophys. 2025 Feb 13. doi: 10.1007/s12013-025-01673-x.
2
AUP1 transcriptionally activated by KDM5B reprograms lipid metabolism to promote the malignant progression of cervical cancer.
Int J Oncol. 2024 Nov;65(5). doi: 10.3892/ijo.2024.5695. Epub 2024 Sep 27.
3
Regulation of cellular and molecular markers of epithelial-mesenchymal transition by Brazilin in breast cancer cells.
PeerJ. 2024 May 9;12:e17360. doi: 10.7717/peerj.17360. eCollection 2024.
4
Context-dependent roles for ubiquitous mitochondrial creatine kinase CKMT1 in breast cancer progression.
Cell Rep. 2024 Apr 23;43(4):114121. doi: 10.1016/j.celrep.2024.114121. Epub 2024 Apr 12.
5
Could MMP3 and MMP9 Serve as Biomarkers in EBV-Related Oropharyngeal Cancer.
Int J Mol Sci. 2024 Feb 22;25(5):2561. doi: 10.3390/ijms25052561.
6
Intercellular transfer of cancer cell invasiveness via endosome-mediated protease shedding.
Nat Commun. 2024 Feb 10;15(1):1277. doi: 10.1038/s41467-024-45558-8.
7
The TIMP protein family: diverse roles in pathophysiology.
Am J Physiol Cell Physiol. 2024 Mar 1;326(3):C917-C934. doi: 10.1152/ajpcell.00699.2023. Epub 2024 Jan 29.
8
Targeting vascular normalization: a promising strategy to improve immune-vascular crosstalk in cancer immunotherapy.
Front Immunol. 2023 Dec 15;14:1291530. doi: 10.3389/fimmu.2023.1291530. eCollection 2023.
9
Effects of Kojic Acid-mediated Sonodynamic Therapy as a Matrix Metalloprotease-9 Inhibitor against Oral Squamous Cell Carcinoma: A Bioinformatics Screening and Analysis.
Curr Drug Discov Technol. 2024;21(4):e011223224137. doi: 10.2174/0115701638266082231124055825.
10
Single-cell aggrephagy-related patterns facilitate tumor microenvironment intercellular communication, influencing osteosarcoma progression and prognosis.
Apoptosis. 2024 Apr;29(3-4):521-535. doi: 10.1007/s10495-023-01922-5. Epub 2023 Dec 8.
本文引用的文献
1
Diverse matrix metalloproteinase functions regulate cancer amoeboid migration.
Nat Commun. 2014 Jun 25;5:4255. doi: 10.1038/ncomms5255.
2
In vivo imaging of membrane type-1 matrix metalloproteinase with a novel activatable near-infrared fluorescence probe.
Cancer Sci. 2014 Aug;105(8):1056-62. doi: 10.1111/cas.12457. Epub 2014 Jul 31.
3
A new transcriptional role for matrix metalloproteinase-12 in antiviral immunity.
Nat Med. 2014 May;20(5):493-502. doi: 10.1038/nm.3508. Epub 2014 Apr 28.
4
Matrix metalloproteinase 7 is a useful marker for 5-fluorouracil-based adjuvant chemotherapy in stage II and stage III colorectal cancer patients.
Med Oncol. 2014 Mar;31(3):824. doi: 10.1007/s12032-013-0824-0. Epub 2014 Jan 28.
5
Induction of autophagy biomarker BNIP3 requires a JAK2/STAT3 and MT1-MMP signaling interplay in Concanavalin-A-activated U87 glioblastoma cells.
Cell Signal. 2014 May;26(5):917-24. doi: 10.1016/j.cellsig.2014.01.012. Epub 2014 Jan 22.
6
Molecular imaging for cancer diagnosis and surgery.
Adv Drug Deliv Rev. 2014 Feb;66:90-100. doi: 10.1016/j.addr.2013.09.007. Epub 2013 Sep 22.
7
Enhanced anticancer activity of nanopreparation containing an MMP2-sensitive PEG-drug conjugate and cell-penetrating moiety.
Proc Natl Acad Sci U S A. 2013 Oct 15;110(42):17047-52. doi: 10.1073/pnas.1304987110. Epub 2013 Sep 23.
8
Coupling protein engineering with probe design to inhibit and image matrix metalloproteinases with controlled specificity.
J Am Chem Soc. 2013 Jun 19;135(24):9139-48. doi: 10.1021/ja403523p. Epub 2013 Jun 6.
9
Matrix metalloproteinases in cancer: their value as diagnostic and prognostic markers and therapeutic targets.
Tumour Biol. 2013 Aug;34(4):2041-51. doi: 10.1007/s13277-013-0842-8. Epub 2013 May 17.
10
The hemopexin domain of MMP3 is responsible for mammary epithelial invasion and morphogenesis through extracellular interaction with HSP90β.
Genes Dev. 2013 Apr 1;27(7):805-17. doi: 10.1101/gad.211383.112.
Zotero 插件